The alliance of mesenchymal stem cells, bone, and diabetes

Area of Science:

• Endocrinology
• Orthopedics
• Cell Biology

Background:

• Bone fragility is an emerging complication of diabetes mellitus.
• Diabetes disrupts bone homeostasis by affecting osteoblast, osteoclast, and osteocyte interactions.
• Mesenchymal stem cell differentiation into osteoblasts may be altered in diabetic patients.

Purpose of the Study:

• To review the mechanisms linking diabetes to impaired bone health.
• To describe factors that negatively impact bone in diabetic individuals.
• To discuss the clinical implications of diabetes-related bone fragility.

Main Methods:

• Literature review of studies on diabetes and bone metabolism.
• Analysis of cellular and structural mechanisms affecting bone in diabetes.
• Synthesis of clinical data on bone complications in diabetes.

Main Results:

• Diabetes impairs bone homeostasis through cellular dysfunction and altered bone structure.
• Mesenchymal stem cells, crucial for bone repair, are affected by diabetes.
• Multiple factors contribute to increased fracture risk in diabetic patients.

Conclusions:

• Diabetes significantly compromises bone health through various interconnected mechanisms.
• Understanding these factors is crucial for managing bone fragility in diabetic patients.
• Further research is needed to develop targeted therapeutic strategies.